1483 related articles for article (PubMed ID: 15944709)
1. c-Myc-regulated microRNAs modulate E2F1 expression.
O'Donnell KA; Wentzel EA; Zeller KI; Dang CV; Mendell JT
Nature; 2005 Jun; 435(7043):839-43. PubMed ID: 15944709
[TBL] [Abstract][Full Text] [Related]
2. Intricate crosstalk between MYC and non-coding RNAs regulates hallmarks of cancer.
Swier LJYM; Dzikiewicz-Krawczyk A; Winkle M; van den Berg A; Kluiver J
Mol Oncol; 2019 Jan; 13(1):26-45. PubMed ID: 30451365
[TBL] [Abstract][Full Text] [Related]
3. Repression of developmental transcription factor networks triggers aging-associated gene expression in human glial progenitor cells.
Mariani JN; Mansky B; Madsen PM; Salinas D; Kesmen D; Huynh NPT; Kuypers NJ; Kesel ER; Bates J; Payne C; Chandler-Militello D; Benraiss A; Goldman SA
Nat Commun; 2024 May; 15(1):3873. PubMed ID: 38719882
[TBL] [Abstract][Full Text] [Related]
4. Gold-Based Pharmacophore Inhibits Intracellular MYC Protein.
Ofori S; Gukathasan S; Awuah SG
Chemistry; 2021 Feb; 27(12):4168-4175. PubMed ID: 33275307
[TBL] [Abstract][Full Text] [Related]
5. MiRNAs confer phenotypic robustness to gene networks by suppressing biological noise.
Siciliano V; Garzilli I; Fracassi C; Criscuolo S; Ventre S; di Bernardo D
Nat Commun; 2013; 4():2364. PubMed ID: 24077216
[TBL] [Abstract][Full Text] [Related]
6.
Acón M; Geiß C; Torres-Calvo J; Bravo-Estupiñan D; Oviedo G; Arias-Arias JL; Rojas-Matey LA; Edwin B; Vásquez-Vargas G; Oses-Vargas Y; Guevara-Coto J; Segura-Castillo A; Siles-Canales F; Quirós-Barrantes S; Régnier-Vigouroux A; Mendes P; Mora-Rodríguez R
iScience; 2021 Dec; 24(12):103407. PubMed ID: 34877484
[TBL] [Abstract][Full Text] [Related]
7. Widespread microRNA repression by Myc contributes to tumorigenesis.
Chang TC; Yu D; Lee YS; Wentzel EA; Arking DE; West KM; Dang CV; Thomas-Tikhonenko A; Mendell JT
Nat Genet; 2008 Jan; 40(1):43-50. PubMed ID: 18066065
[TBL] [Abstract][Full Text] [Related]
8. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.
Lee RC; Feinbaum RL; Ambros V
Cell; 1993 Dec; 75(5):843-54. PubMed ID: 8252621
[TBL] [Abstract][Full Text] [Related]
9. A microRNA expression signature of human solid tumors defines cancer gene targets.
Volinia S; Calin GA; Liu CG; Ambs S; Cimmino A; Petrocca F; Visone R; Iorio M; Roldo C; Ferracin M; Prueitt RL; Yanaihara N; Lanza G; Scarpa A; Vecchione A; Negrini M; Harris CC; Croce CM
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2257-61. PubMed ID: 16461460
[TBL] [Abstract][Full Text] [Related]
10. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters.
Ventura A; Young AG; Winslow MM; Lintault L; Meissner A; Erkeland SJ; Newman J; Bronson RT; Crowley D; Stone JR; Jaenisch R; Sharp PA; Jacks T
Cell; 2008 Mar; 132(5):875-86. PubMed ID: 18329372
[TBL] [Abstract][Full Text] [Related]
11. An E2F/miR-20a autoregulatory feedback loop.
Sylvestre Y; De Guire V; Querido E; Mukhopadhyay UK; Bourdeau V; Major F; Ferbeyre G; Chartrand P
J Biol Chem; 2007 Jan; 282(4):2135-43. PubMed ID: 17135249
[TBL] [Abstract][Full Text] [Related]
12. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster.
Dews M; Homayouni A; Yu D; Murphy D; Sevignani C; Wentzel E; Furth EE; Lee WM; Enders GH; Mendell JT; Thomas-Tikhonenko A
Nat Genet; 2006 Sep; 38(9):1060-5. PubMed ID: 16878133
[TBL] [Abstract][Full Text] [Related]
13. A microRNA component of the p53 tumour suppressor network.
He L; He X; Lim LP; de Stanchina E; Xuan Z; Liang Y; Xue W; Zender L; Magnus J; Ridzon D; Jackson AL; Linsley PS; Chen C; Lowe SW; Cleary MA; Hannon GJ
Nature; 2007 Jun; 447(7148):1130-4. PubMed ID: 17554337
[TBL] [Abstract][Full Text] [Related]
14. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
Hayashita Y; Osada H; Tatematsu Y; Yamada H; Yanagisawa K; Tomida S; Yatabe Y; Kawahara K; Sekido Y; Takahashi T
Cancer Res; 2005 Nov; 65(21):9628-32. PubMed ID: 16266980
[TBL] [Abstract][Full Text] [Related]
15. miR-15 and miR-16 induce apoptosis by targeting BCL2.
Cimmino A; Calin GA; Fabbri M; Iorio MV; Ferracin M; Shimizu M; Wojcik SE; Aqeilan RI; Zupo S; Dono M; Rassenti L; Alder H; Volinia S; Liu CG; Kipps TJ; Negrini M; Croce CM
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13944-9. PubMed ID: 16166262
[TBL] [Abstract][Full Text] [Related]
16. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes.
Xiao C; Srinivasan L; Calado DP; Patterson HC; Zhang B; Wang J; Henderson JM; Kutok JL; Rajewsky K
Nat Immunol; 2008 Apr; 9(4):405-14. PubMed ID: 18327259
[TBL] [Abstract][Full Text] [Related]
17. miR-19 is a key oncogenic component of mir-17-92.
Olive V; Bennett MJ; Walker JC; Ma C; Jiang I; Cordon-Cardo C; Li QJ; Lowe SW; Hannon GJ; He L
Genes Dev; 2009 Dec; 23(24):2839-49. PubMed ID: 20008935
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA gene expression deregulation in human breast cancer.
Iorio MV; Ferracin M; Liu CG; Veronese A; Spizzo R; Sabbioni S; Magri E; Pedriali M; Fabbri M; Campiglio M; Ménard S; Palazzo JP; Rosenberg A; Musiani P; Volinia S; Nenci I; Calin GA; Querzoli P; Negrini M; Croce CM
Cancer Res; 2005 Aug; 65(16):7065-70. PubMed ID: 16103053
[TBL] [Abstract][Full Text] [Related]
19. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.
Chang TC; Wentzel EA; Kent OA; Ramachandran K; Mullendore M; Lee KH; Feldmann G; Yamakuchi M; Ferlito M; Lowenstein CJ; Arking DE; Beer MA; Maitra A; Mendell JT
Mol Cell; 2007 Jun; 26(5):745-52. PubMed ID: 17540599
[TBL] [Abstract][Full Text] [Related]
20. miRiad roles for the miR-17-92 cluster in development and disease.
Mendell JT
Cell; 2008 Apr; 133(2):217-22. PubMed ID: 18423194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
